High-quality statistics, at every stage, from study design through to analysis and interpretation, are essential to building study credibility. Our vast expertise in a wide range of therapeutic areas will support you as your study progresses through every stage from I – IV.
Working on a project team basis, our statisticians can see each of your studies through from protocol and CRF design to the statistical report stage. They are able to develop full analysis plans or work directly to your own specifications to implement the core objectives of your trial. All critical endpoint analysis is reviewed by dual independent programming and subject to quality assurance review.
Our dedicated team of statisticians have significant experience in analysing clinical data across Phases I – IV with endpoints involving safety, pharmacodynamics (PD), and pharmacokinetics (PK) under various therapeutic areas. These include oncology, respiratory, neurosciences, infectious diseases, dermatology, urology, cardiovascular, psychiatry, ophthalmology, inflammation and many more.
Synergy’s statistical consultancy services include:
Protocol development (study design and statistical analysis)
Advice on CRF development
Treatment randomisation
Sample size calculation
Power analysis
Statistical analysis plans for reporting data
Drafting statistical reports
Input to clinical study reports and publications
Whatever your requirements, or length of project, you can rest assured that we will partner with you to deliver an appropriate and cost-effective solution.